These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22301823)

  • 1. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center.
    Besada E; Koldingsnes W; Nossent J
    QJM; 2012 Jun; 105(6):545-50. PubMed ID: 22301823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset neutropenia in patients with rheumatoid arthritis after treatment with rituximab.
    Abdulkader R; Dharmapalaiah C; Rose G; Shand LM; Clunie GP; Watts RA
    J Rheumatol; 2014 May; 41(5):858-61. PubMed ID: 24634201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenia after rituximab treatment: new insights on a late complication.
    Wolach O; Shpilberg O; Lahav M
    Curr Opin Hematol; 2012 Jan; 19(1):32-8. PubMed ID: 22080846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.
    Tesfa D; Ajeganova S; Hägglund H; Sander B; Fadeel B; Hafström I; Palmblad J
    Arthritis Rheum; 2011 Aug; 63(8):2209-14. PubMed ID: 21560117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.
    Tesfa D; Palmblad J
    Expert Rev Hematol; 2011 Dec; 4(6):619-25. PubMed ID: 22077526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.
    Wolach O; Bairey O; Lahav M
    Medicine (Baltimore); 2010 Sep; 89(5):308-318. PubMed ID: 20827108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late-onset neutropenia following rituximab therapy as a treatment of diffuse large B-cell lymphoma: a single institution study].
    Kim M; Lee JK; Hong YJ; Hong SI; Kang HJ; Chang YH
    Korean J Lab Med; 2010 Dec; 30(6):575-9. PubMed ID: 21157141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature.
    Monaco WE; Jones JD; Rigby WF
    Clin Rheumatol; 2016 Oct; 35(10):2457-62. PubMed ID: 27209045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-induced late-onset neutropenia in newly diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism.
    Li SC; Chen YC; Evens AM; Lee CC; Liao HF; Yu CC; Tung YT; Su YC
    Am J Hematol; 2010 Oct; 85(10):810-2. PubMed ID: 20730791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset neutropenia following rituximab treatment for rheumatologic conditions.
    Breuer GS; Ehrenfeld M; Rosner I; Balbir-Gurman A; Zisman D; Oren S; Paran D
    Clin Rheumatol; 2014 Sep; 33(9):1337-40. PubMed ID: 24599679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study.
    Ishida H; Inui M; Furusawa M; Tanabe K
    Transpl Immunol; 2013 Mar; 28(2-3):93-9. PubMed ID: 23353568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.
    Parodis I; Söder F; Faustini F; Kasza Z; Samuelsson I; Zickert A; Svenungsson E; van Vollenhoven RF; Malmström V; Wermeling F; Gunnarsson I
    Lupus; 2018 Aug; 27(9):1470-1478. PubMed ID: 29783918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia associated with rituximab therapy.
    Grant C; Wilson WH; Dunleavy K
    Curr Opin Hematol; 2011 Jan; 18(1):49-54. PubMed ID: 21102324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
    Lai GG; Lim ST; Tao M; Chan A; Li H; Quek R
    Am J Hematol; 2009 Jul; 84(7):414-7. PubMed ID: 19415727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
    Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
    Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-Onset Neutropenia After Rituximab-Containing Therapy for Non-Hodgkin Lymphoma.
    Aguiar-Bujanda D; Blanco-Sánchez MJ; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura-Grau S; Bohn-Sarmiento U
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):761-5. PubMed ID: 26319620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.
    Ajeganova S; Tesfa D; Hägglund H; Fadeel B; Vedin I; Zignego AL; Palmblad J
    Arthritis Res Ther; 2017 Mar; 19(1):44. PubMed ID: 28270182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
    Knight A; Sundström Y; Börjesson O; Bruchfeld A; Malmström V; Gunnarsson I
    Scand J Rheumatol; 2016 Oct; 45(5):404-7. PubMed ID: 26948245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study.
    Nitta E; Izutsu K; Sato T; Ota Y; Takeuchi K; Kamijo A; Takahashi K; Oshima K; Kanda Y; Chiba S; Motokura T; Kurokawa M
    Ann Oncol; 2007 Feb; 18(2):364-9. PubMed ID: 17079695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma.
    Arai Y; Yamashita K; Mizugishi K; Nishikori M; Hishizawa M; Kondo T; Kitano T; Kawabata H; Kadowaki N; Takaori-Kondo A
    Hematology; 2015 May; 20(4):196-202. PubMed ID: 25130775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.